Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
about
Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA VaccineAlphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunityComparison of the immune responses induced by chimeric alphavirus-vectored and formalin-inactivated alum-precipitated measles vaccines in miceDNA vaccines: developing new strategies against cancer.A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measlesThe extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccinesRIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replicationImproved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypesSuperior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine.Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in miceDendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseRole of TLR3 in the immunogenicity of replicon plasmid-based vaccines.Contribution of IRF-3 mediated IFNbeta production to DNA vaccine dependent cellular immune responsesmRNA vaccination as a safe approach for specific protection from type I allergy.Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants.Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.NF-κB activation during intradermal DNA vaccination is essential for eliciting tumor protective antigen-specific CTL responses.
P2860
Q27485003-3EA3CE52-B81F-4455-9F4C-C2C3CC5D7E92Q28749317-074B7083-4FA2-4AA8-9CB4-AB5EFE02E0E6Q28752489-B13C8A14-ABBF-453E-B33E-C3557096D990Q33756622-A5B416D1-95E4-4EFF-8934-8CBD039A5E59Q33769306-328E9EAC-5493-4FBB-B7FA-A3996A624359Q34025333-93D03B31-2346-4E41-A9EE-C089EBEF4126Q34573907-8219C804-0749-4D2A-9FE1-BED6D81EE781Q34988003-2463DB81-CB8D-41F2-8ACD-3B1186773AA3Q35353052-16A8F90B-B23B-4719-B965-CE966D697482Q35868091-BC7307E7-CA98-4E0F-B32C-153A9B0C8A02Q36456487-104272BF-9464-402A-A30C-4FE2B3943F16Q36677419-93DB7E71-9E18-497A-8574-F26DE16FDA6DQ37019912-400CC29E-DF2D-45B9-B7CA-ED76038B33D3Q37126611-404B9D6A-2457-46A4-A954-070E04323972Q37127370-7333DF8B-D3A5-456C-BBBA-7509703AF514Q37155554-DE3E6B89-B230-45EF-853D-2E7C03BA491AQ37965722-64A39265-C0A2-4B7C-A7CA-32DD14D3442FQ39265708-7463CB54-B714-485B-A64E-80D5955F4AA7Q40252348-6C2AED09-3C1F-425C-987D-46E2CA5F6D28Q42998966-57F40095-7CCE-4A40-879C-9FED00BF9D5DQ45723785-42B97D9A-F32A-48F6-BC02-4FDEAB4BCAB1
P2860
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@ast
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@en
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@nl
type
label
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@ast
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@en
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@nl
prefLabel
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@ast
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@en
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.
@nl
P2860
P50
P1433
P1476
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines
@en
P2093
Leroy N Hwang
P2860
P304
P356
10.1016/J.VACCINE.2006.04.059
P407
P577
2006-05-06T00:00:00Z